Novo Nordisk A/S vs J M Smucker Co — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while J M Smucker Co trades at $112.69 (market cap $11.97B). The key difference: Novo Nordisk A/S is far larger — about 18.4× J M Smucker Co's market cap, and J M Smucker Co pays the higher dividend (3.93%). Which is the better fit depends on your goals.
| NVO | SJM | |
|---|---|---|
Market Cap | $220.53B | $11.97B |
Sector | Health | Consumer Staples |
52-Week High | $71.70 | $117.05 |
52-Week Low | $35.29 | $89.53 |
Enterprise Value | $239.49B | $19.00B |
Dividend Yield | 3.63% | 3.93% |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →